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A family of octamer binding proteins is expressed during
mouse development. Oct4 and Oct-6 have been identified
as two octamer binding proteins present in embryonal
stem cells. Here we report the complementary DNA
cloning and characterization of the mouse Oct41 gene. The
protein of 448 amino acids contains a glycine/alanine-rich
amino terminal region, a histidine-rich sequence with
homology to a region of kininogen associated with
clotting, a POU domain and a short proline/histidine-rich
carboxy terminal region. Expression of Oct46 in HeLa
cells is sufficient for transcriptional activation from the
octamer motif, identifying Oct46 as a transcription factor.
The Oct46 expression is downregulated upon embryonic
stem cell differentiation increasing again during brain
development. Expression in brain is present in certain
areas of telecephalon, mesencephalon and brain stem
with abundant expression in the cortex anlagen and in
the developing colliculi. Thus Oct41 is a new octamer
binding transcription factor specifically regulated during
mouse development.
Key words: brain development/embryogenesis/octamer/POU
gene/transcription factor
Introduction
Development begins with a fertilized oocyte that gives rise
to diverse cells with differing fates. Current models of
development are based primarily on the molecular
embryology of Drosophila and postulate a hierarchy of
regulatory genes guiding the transfer of genetic information
into embryonic structures (reviewed in Akam, 1987; Ingham,
1988). Establishment of diverse cell fates during
embryogenesis requires differential gene expression that is
modulated by specific regulatory proteins (reviewed in
Davidson, 1990). The identification of murine regulatory
proteins specific for early stages of embryogenesis might
unravel important members of a regulatory hierarchy in the
mouse.
Members of a family of Oct-proteins bind to the octamer
motif (Scholer et al., 1989a), a cis-acting regulatory element
found in many promoters and enhancers and stimulate
transcription via the octamer motif (reviewed in Falkner
et al., 1986; Hatzopoulos et al., 1988; Schaffner, 1989;
Schreiber et al., 1989). In undifferentiated embryonal
carcinoma (EC) cells, the octamer motif mediates both
transcriptional activation (Scholer et al., 1989b) and repres-
sion (Lenardo et al., 1989). Three octamer binding proteins
might account for these opposite activities, namely Oct4,
Oct-5 and Oct-6 (Scholer et al., 1989a). Oct-4 and Oct-5
are encoded by the Oct-4 gene (Scholer et al., l990a;
1990b).
Here we report the cDNA sequence of the third EC
octamer binding protein Oct-6 as well as its expression
during mouse development. The cDNA encodes a protein
of 448 amino acids containing a POU domain (Herr et al.,
1988) identical to Tst-l and SCIP (He et al., 1989; Monuki
et al., 1989). A stretch of 8 amino acids between the
potential helices 1 and 2 of the POU homeodomain has been
conserved between both EC proteins Oct-6 and Oct-4,
although both proteins otherwise diverge. Ectopic expression
of Oct-6 cDNA was sufficient to activate transcription from
the octamer motif, indicating that Oct-6 is a transcription
factor. Expression of the Oct-6 gene during embryogenesis
was analyzed by in situ hybridization, Northern blot analysis,
RNase protection and DNA binding studies. We demonstrate
Oct-6 expression in embryonal stem cells and in developing
brain and adult testis. With the proteolytic clipping assay
the presence and identity of Oct-6 in brain cortex is shown.
These studies suggest that the transcription factor Oct46 might
control events at very early and late stages of murine
development.
Results
Identification of cDNA clones encoding Oct-6
Four DNA-protein complexes are detectable with the
octamer motif in undifferentiated F9 EC cells in the
electrophoretic mobility shift assay (EMSA) (named Oct-i,
Oct-4, Oct-5 and Oct-6 according to Scholer et al., 1989a).
A cDNA library prepared from F9 cells was screened
with a probe spanning the mouse Oct-2 POU domain
(Hatzopoulos et al., 1990). Three groups of clones encoding
octamer binding proteins were isolated. Clones of the first
group encoded Oct-I and those of the second Oct-4 and Oct-5
(Scholer et al., 1990a). About one-third of the recombinant
clones, comprised a third group and were tentatively assigned
as incomplete Oct-6 clones.
These cDNAs encode a protein with a POU domain
identical to rat Tst-I and SCIP (He et al., 1989; Monuki
et al., 1989). Probes from both, Tst-1 and SCIP, detect brain
mRNA (He et al., 1989; Monuki et al., 1989). The POU
domain of Tst-l/SCIP is alinost identical to Bin-I and Brn-2
(He et al., 1989). Thus, although the POU domains for
Tst-1/SCIP and our F9 clones are identical, they may be
derived from different genes. To test this and in order to
obtain longer cDNA clones, we screened a mouse brain
cDNA library with a probe spanning the 5' region of our
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Fig. 1. Structure and sequence of mouse Oct-6. (A) Structure and length of the longest Oct-6 cDNA clones derived from F9 (960 bp) and brain
(1504 bp) libraries are shown. The POU-specific domain, the POU-homoeodomain and the fragments used for the analysis of the Oct-6 gene are
indicated. Fragment A: nt 549-nt 708 (160 bp). (B) Comparison of the product of the brain cDNA cone with F9 octamer binding proteins.
Radiolabeled octamer probe was incubated before electrophoresis with a F9 whole cell extract (lane 1) or with in vitro translated product of the brain
cDNA clone (lane 2). Before transcription the clone was restricted at the unique BamHI site in the linker 3' of the coding sequence. For generation
of anti-sense RNA the clone was cut at the unique Hindll site in the linker 5' of the coding sequence. The sense and anti-sense RNA was translated
with a reticulocyte lysate and analyzed in the EMSA as described in Materials and methods (anti-sense RNA translation not shown). The
nomenclature of the octamer binding proteins is according to Schbler et al. (1989a). (C) Nucleotide sequence of the entire cDNA sequence derived
from the longest brain cDNA clone. Numbering (right, nucleotide sequence; left, amino acid sequence in single-letter code) begins at the putative
initiation codon. The POU specific domain, the POU homoeodomain and the four possible helices of the POU homoeodomain are boxed. The 5' end
of the longest F9 clone, the possible hinge region between helices and 2 of the POU homoeodomain and certain restriction sites are indicated.
Alanine/glycine-rich sequences are underlined.
clones and lacking any POU sequences (probe A; Figure
IA).
The inserts of the clones isolated by this procedure were
analyzed by sequential in vitro transcription, translation and
finally by DNA binding in the EMSA. The product of the
longest clone (brain, Figure IA) had the same mobility as
Oct-6 (Figure iB). Nucleotide sequence comparison (Figure
IC) and Southern blot analysis of mouse genomic DNA (not
shown) demonstrated that the F9 and brain clones are derived
from the same gene. Therefore the brain Oct-6 cDNA clone
was used in subsequent experiments.
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Expression pattern of the Oct-6 gene
The expression pattern of the Oct-6 gene was examined first
by Northern blot analysis. Given the strong sequence
similarity between the POU domains of the Oct-genes, this
domain was excluded from hybridization probes. Fragment
A (Figure lA), hybridized to transcripts of 3.6 and 2.8 kb
length in RNA from F9 stem cells, testis and brain (Figure
2A). These transcripts were not detected in any other tissue.
In F9 cells the signal obtained for Oct-6 RNA is weaker than
that of Oct-4 RNA and thus correlates with Oct-6 and Oct-4
binding activity found in EMSAs (not shown). Additionally,
N.Suzuki et al.






Fig. 2. Expression pattern of the Oct-6 gene. (A) Northern blot
analysis with F9 cell RNA and RNAs of a limited number of adult
tissues. Poly (A)+ RNAs (20 1g) prepared from the indicated samples
were run on a formaldehyde-agarose gel and were analyzed by
Northern blot hybridization. In case of brain RNA both, poly (A)+
RNA and whole cell RNA were analyzed. RNAs in each lane were
intact based on ethidium bromide staining and hybridization with a ras
DNA probe. (B) Autoradiograph of RNase protection assays with
RNAs representing different embryonic stages and from adult brain as
indicated at the top of the figure. The position of the full probe and
the protected probe (152 nucleotides) are indicated. 30 jig total RNA
was used in the experiments, except for 5 Ag F9 RNA.
the probe hybridized to a 2.3 kb mRNA, in brain and testis
RNA but not in F9 RNA. The 3.6 kb RNA represents the
major Oct-6 mRNA in F9 stem cells and brain. In testis each
RNA species is found less abundant and in approximately
equimolar amounts. The lengths of these mRNAs are distinct
from those found in testis and brain of adult rat where they
are 4.4 and 7.6 kb, respectively (He et al., 1989). The
predominant 3.6 kb Oct-6 mRNA might correspond to the
predominant Tst-1/SCIP species (3 kb) in postnatal and
young adult rats (Monuki et al., 1989).
RNase protection assays confirmed the identity of the
reactive RNAs as authentic transcripts of the Oct-6 gene
(Figure 2B). Anti-sense RNA was prepared from the same
fragment as used for the Northern blot analysis. Again, Oct-6
transcripts were detected in F9 cells, in brain and in testis
(Figure 2B; testis RNA not shown), again no signal was
obtained with RNA from differentiated F9 cells (Figure 2A
and B). Thus the decrease of Oct-6 RNA correlates with
the decrease of Oct-6 binding activity during F9 stem cell
differentiation (Scholer et al., 1989a). Using the RNase
protection assay the analysis was extended to the embryonal
stem (ES) cell line D3 (Doetschman et al., 1985) (Figure
2B). Because ES cells are totipotent stem cells derived from
the inner cell mass of murine blastocysts (Gardner and
Rossant, 1979; Evans and Kaufman, 1981; Martin, 1981),
these cells represent a very early embryonic stage. As in
F9 cells, a protected band was obtained with D3 stem cell
but not with D3 cells differentiated in vitro (Figure 2B).
Finally, expression was examined in mouse embryos from
day 10 to day 15. Weak expression was detected at
embryonic day 10 and day 11, respectively. By day 12 a
strong signal was obtained, indicating that Oct-6 expression


















Fig. 3. Localization of Oct-6 transcripts within the developing brain.
Mid-sagittal and para-sagittal sections through brains of different
embryonic days were hybridized with an Oct-6 specific anti-sense
RNA probe. Bright-field (left) and dark-field images (right) show brain
sections of day 10 (A, B), 12(C, D), 14 (E, F, G, H), 16 (I, J) and
17 (K, L) embryos. (cb) indicates cerebellum, (ic) inferior colliculus,
(mes) mesencephalon, (met) metencephalon, (mf) mesencephalic
flexure, (my) myelencephalon/medulla, (ob) olfactory bulb, (pe)
prosencephalon (pe 1) prospective striatum, (pe 2) prospective
thalamus, (rhe) rhombencephalon and (sc) superior colliculus.
Spatial expression of the Oct-6 gene durng mouse
development
The distribution of Oct-6 transcripts during mouse
embryogenesis was determined by in situ hybridization.
Sense and anti-sense RNA probes were transcribed from
linearized plasmids containing a 160 bp Oct-6 cDNA insert
(Figure IA, Fragment A).
To determine the precise expression pattern in the














embryos from day 10 to day 17 were analyzed (Figure 3).
Continuous expression in defined regions of prosencephalon
(pe), mesencephalon (mes) and rhombencephalon (rhe) was
observed (Figure 3). Brains of day 10 embryos showed faint
expression in cell clusters in the floor plate of the
prosencephalon, mesencephalon and rhombencephalon as
well as in the mesencephalic roof (Figure 3A and B).
By day 12 expression in these areas had increased
significantly (Figure 3C and D). Two distinct cell groups
were visible in the prosencephalic floor, one in the ventral
half of the prospective striatum (pe 1), the other in a region
that gives rise to the thalamus (pe 2). The prosencephalic
roof, which develops into the diencephalic roof plate, was
also positive for Oct-6 expression. In the mesencephalon,
expression included the ventral mesencephalic flexure. A
signal was detectable in the mesencephalic roof, which gives
rise to superior (sc) and inferior (ic) colliculi and also in
the metencephalon which gives rise to the cerebellum (cb).
Oct-6 expression was found also in the developing pons (pn)
and myelencephalon/medulla (my). All zones of expression
are within the intermediate layer of the developing central
nervous system, where neurons and glioblasts start to
differentiate (Rickman and Wolff, 1985).
At day 14 the number of Oct-6 positive cells in the
intermediate layer had increased and formed aggregates.
Expression was found within the ventral pons and the ventral
medulla. Positive cell aggregates were found ventral of the
prospective striatum, along the mesencephalic flexure, and
within the thalamus (not shown). In addition, expression was
detected in the developing cerebral cortex, olfactory bulb
(ob), but not within the cerebellum. Oct-6 expression was
also found in the superior colliculi and strongly in the inferior
colliculi of the mesencephalic roof. Both colliculi serve as
centers for visual and auditorial correlation. The superior
colliculi are primary receptive centers for the optic tracts
and are linked to the inferior colliculi which, in turn, connect
with the cochlear nuclei of the pons.
A similar pattern was observed for day 16 and day 17,
with increased expression in the cerebral cortex (Figure 3
I to L). Expression continued in the cerebral cortex and the
olfactory bulb of adult mice, whereas superior colliculus and
the thalamus were negative for Oct-6 expression (not shown).
In situ hybridization was also used to investigate Oct-6
transcription at the blastocyst stage. However, in contrast
to results obtained with the Oct4 gene (Scholer et al.,
1990b), Oct-6 transcripts could not be detected (data not
shown).
Expression of Oct-6 protein in embryonal stem cells
and in the developing brain
In a previous report we described a DNA protein complex
specfic for the frontal cortex and subcortical regions of rat brain
(Scholer et al., 1989a). Prolonged electrophoresis showed that
the mobility of this complex was identical to that of F9 Oct-6
and slightly higher than that of brain Oct-3. The brain-specific
protein had been originally named Oct-3 by us (Scholer et al.,
1989a) but unfortunately the same term is now used by others
(Okamoto et al., 1990; Rosner et al., 1990) for the Oct-4 pro-
tein (Scholer et al., 1989a, b; 1990a, b). To distinguish F9
Oct-3 from brain Oct-3 and to avoid further ambiguities, those
octamer-binding proteins that are expressed in the nervous
system will be named NOct proteins.
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Fig. 4. Oct-6 is present in ES cells and brain. (A) Comparison of
Oct-6 translated in vitro with Oct-6 ectopically expressed in HeLa
cells. Before application to the EMSA, Oct-6 was either expressed by
in vitro transcription and subsequent translation in a rabbit reticulocyte
extract (lane 2) or by a SV40 promoter-driven expression vector in
HeLa cells (lane 4). As controls, Oct-4 translated in vitro (lane 3), and
F9 octamer binding proteins are shown (lane 1). For details of
expression see legend of Figure 7. (B) Comparison of embryonal stem
cell Oct-6 and NOct-6. Radiolabeled octamer probe was incubated
before electrophoresis with whole cell extracts of either undifferentiated
F9 cells (lane 1), D3 stem cells (lane 2), cortex (lane 3) or cerebellum
(lane 4) of day-3 newborn mice, and with Oct-6 (lane 6) or Oct-2A
(lane 7) expressed in HeLa cells. The octamer binding proteins are
named according to Scholer et al. (1989a).
NOct-6 and NOct-3 we examined if Oct-6 is modified in vivo.
For this purpose, Oct-6 prepared by in vitro translation of the
Oct-6 cDNA was compared in the EMSA with Oct-6 produced
ectopically in HeLa cells (for expression details see below).
In both cases the protein gave a band at the same position,
indicating that Oct-6 is either not modified in HeLa cells or
that the modification is not detectable in the EMSA (Figure 4A).
Next we examined if cells and tissues containing Oct-6
RNA give a complex with identical mobility in the EMSA.
Therefore, the Oct-6 protein was expressed in HeLa cells
and compared with F9, D3 and cortex extracts (Figure 4B).
Cerebellum of newborn mice was used as a negative control,
as Oct-6 RNA had not been found by in situ analysis.
Moreover, cerebellum extract gives most of the Oct
complexes in the EMSA; the complexes not found in
cerebellum, are in extracts of F9, D3 or cortex. Each source
that had been shown to be positive for Oct-6 RNA gave a
complex at the expected position (compare lane 6 with lanes
1 to 3), whereas the cerebellum is negative for both Oct-6
RNA and NOct-6 protein (lane 4). In this experiment the
presence of Oct-6 RNA correlates with that of the NOct-6
complex.
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Oct-6 in the developing brain
because in addition to NOct-3 another complex was
comigrating with NOct-6 in the EMSA. The protein is found
in virtually every cellular extract with a slightly higher
mobility than NOct-6 (for example Figure 8A, where this
complex is indicated with an arrow). Competition
experiments and binding to fragments with the mutated
octamer motif defines it as an unspecific binding protein (not
shown). The unspecific protein is either found after long
exposure times or when low amounts of competitor are used
(Figure 8A).
Identification of brain Oct-6 by the proteolytic clipping
assay
The presence and identity of Oct-6 in brain was confirmed
by the proteolytic clipping assay (Schreiber et al., 1988;
Scholer et al., 1989a). The octamer binding proteins of
cortex and cerebellum from newborn mice were compared
with Oct-i, Oct-2A and Oct-6 expressed in HeLa cells (for
expression see below). Whole cell extracts were first
incubated with the octamer probe and subsequently digested
with different amounts of the nonspecific endoprotease
dispase (Figure 5A to C; Oct-I and Oct-2 not shown). A
comparison of the proteolytic clipping intermediates showed
that the pattern of cloned Oct-6 (A) is missing in the
experiment with cerebellum extract (C), but could be
identified in the experiment with cortex extract (B). Actually,
the cortex pattern appears to be a combination of that of both
other extracts as schematically presented in Figure 5 D to F.
Although extracts of different brain regions contain quite
a complex set of proteins, the proteolytic clipping assay
demonstrates that NOct-6 is encoded by the Oct-6 gene and
therefore the term Oct-6 will be subsequently used for brain
and F9 Oct-6. This analysis had been simplified by almost
missing NOct-1 and NOct-2 degradation intermediates.
When cloned Oct-I and Oct-2 expressed in HeLa cells are
proteolytically degraded, definite bands are only seen for
the final DNA binding domains (not shown). Fortunately,
these have a higher mobility than that of NOct-3 and Oct-6
as such do not obscure the pattern of NOct-3 and Oct-6
clipping (not shown).
The Oct-6 protein is found in the developing cortex
but not in the cerebellum
The expression pattern of Oct-6 during brain development
was further analyzed by EMSA using extracts of brain
regions at different developmental stages of the mouse.
Cortex, metencephalon (at later stages cerebellum) and
brainstem of embryos, newborn and adult mice were
analyzed (Figure 6). Only a weak Oct-6 signal is detectable
at embryonic day 12 or 15, much less prominent than NOct-3
(lanes 1 to 6). Subsequently, a complex is found both in
cortex and brain extracts, whereas Oct-6 remained absent
in every extract derived from cerebellum (lanes 7 to 19).
In summary, the Oct-6 complex is faintly detectable in brain
of day 12 embryos, increasing significantly thereafter in
cortex and brainstem. Thus the appearance of the Oct-6
complex follows that of Oct-6 RNA. In addition to the
Oct-complexes described previously (Scholer et al., 1989a)
a complex with the same mobility as Oct-2B could be
identified in brainstem and metencephalon (Figure 6).
Structure of the Oct-6 protein
The sequence of the Oct-6 protein was derived from the
longest open reading frame of the brain Oct-6 cDNA clone
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Fig. 5. The degradation pattern of cloned Oct-6 is found with cortex
but not with cerebellum extracts. Whole cell extracts of HeLa cells
containing ectopically expressed Oct-6 (A), extracts of cortex (B) and
of cerebellum (C) from day-3 newborn mice were incubated in parallel
with radiolabelled octamer probe. The extracts are identical to those
used for lanes 9 and 10 of Figure 6. Prior to electrophoresis
increasing amounts of dispase were used. The first lane of each set is
without dispase, the following lanes are with 0.5 (lanes 2), 1 (lanes 3),
2 (lanes 4), 4 (lanes 5), 6 (lanes 6) and 8 (lanes 7) ug dispase. The
positions of cloned Oct-6, NOct-6 and their respective degradation
intermediates are indicated with arrows. Below each analysis the
clipping patterns of cloned Oct-6 (D) and the octamer binding proteins
found in cortex (E) and cerebellum (F) are shown schematically. Black
or cross-striped boxes represent Oct-6 and respective degradation
intermediates, white boxes representing complexes and degradation
intermediates that are found in cerebellum. For each lane 2 ixg protein
were used, except for the very first lane (Oct-6 in HeLa, without
dispase), where 8 jg was used.
(Figures IC and 7). Oct-6 cDNA encodes a protein of 448
amino acids containing a POU domain that is identical to
Tst/SCIP and thus belongs to POU class 111 (He et al., 1989).
The POU domain is located in the carboxy-terminal half of
the protein with 239 and 53 amino acids at the amino- and
carboxy-termini, respectively. As with other POU
homeodomains, the POU homeodomain of Oct-6 is predicted
to contain four helices with clusters of basic amino acids
preceding the first helix, and overlapping the end of the third
and most of the fourth helix (Otting et al., 1988; Garcia-Blanco
et al., 1989; Qian et al., 1989). Another region with basic
amino acids is located in the center of the POU-specific
domain. Sequence comparison shows that both ES proteins,
Oct-6 and Oct-4, contain an identical stretch of eight amino
acids. This stretch is located between helix one and two of
the POU homeodomain and thus might form a hinge between
both helices (Figure IC; Scholer et al., 1990a).
The Oct-6 sequence has four cysteine residues all located
in the POU domain, two in the POU-specific domain and
two in the POU homeodomain. Unexpectedly, binding of
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Fig. 6. Detection of Oct-6 during brain development. Cortex,
metencephalon (or cerebellum) and brainstem of the developmental
stages indicated above the figure were isolated according to Hogan
et al. (1986). Whole cell extracts were prepared and incubated before
electrophoresis with radiolabeled octamer probe. To separate NOct-3
and NOct-6 the time of electrophoresis was doubled. Therefore the
DNA probe could not be shown in the figure. For each lane 6 /g
whole cell extract was used. The octamer binding proteins are named
according to Scholer et al. (1989a).
whereas binding of Oct-I and Oct-2 was not affected.
However, Oct-6 binding was restored completely when
preincubated with DTT, suggesting that the disulfide bridges
need to be disrupted before binding (not shown).
Several sequence features outside the POU domain are
noteworthy, but of unknown significance. First several
contiguous glycine-alanine stretches of up to eight residues
are present. Polyalanine stretches of various lengths are in
Drosophila developmental control genes such as engrailed,
even-skipped and caudal (Poole et al., 1985; McDonald
et al., 1986; Frasch et al., 1987).
Second, a histidine rich region (30%) is found from
position 185 to 228 amino-terminal to the POU domain.
This includes alternating histidine and glycine (or alanine)
residues (HLGAHGHAHGHAHA) and a cluster of four
acidic amino acids. A similar alternating sequence motif
(HGLGHGHKHGHGHG) is found also in the histidine-rich
region of high molecular weight (HMW) kininogen (Kato
et al., 1983; Lottspeich et al., 1985). Interestingly, this
region is associated with the clotting activity of HMW
kininogen. In bovine HMW kininogen a 41 amino acid
fragment (fragment 2; 27% histidine) with this motif is
released by the action of plasma kallikrein, and hereby the
clotting activity is lost (Iwanaga et al., 1979).
Third, proline residues distributed throughout the amino-
terminal half of Oct-6 are interspersed with twelve acidic
and seven basic amino acids. Another region harboring both
proline and acidic amino acid residues follows the POU
domain. Whether any of these acidic regions participate in
transcriptional activation, as has been described for other
acidic domains, remains to be tested (reviewed in Mitchell
and Tjian, 1989).
Finally, contiguous stretches of six proline and of six
histidine residues each are found at the carboxy-terminus
of Oct-6. Even longer rows of proline and histidine residues
are found in other proteins, although, again their significance
is unknown. For example, two stretches of ten and eight
histidine residues are found in Drosophila polycomb
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Fig. 7. Predicted amino-acid sequence (single-letter code) of Oct-6.
The POU specific domain and the POU homoeodomain - and +
indicate acidic and basic amino acids, respectively. Histidine residues
are boxed and proline residues are circled. The cysteine residues are
underlined with thick bars.
(R.Paro, personal communication). Polyproline stretches are
found in several viral proteins. For example, the activity of
the HSV transactivator VP16 is increased by another viral
protein with a polyproline at the carboxy-terminus
(McKnight et al., 1987).
Transactivation by cloned Oct-6
Depending on the context of other transcription elements,
the octamer motif confers transcriptional activation (Scholer
et al., 1989b) or repression (Lenardo et al., 1989) in F9
cells.
The transactivation activity of Oct-6 was compared with
that of Oct-2A (Miiller-Immergliuck et al., 1988) and of
Oct-4 (Scholer et al., 1990b). For this purpose, the Oct-6
coding sequence was cloned in both orientations into an
eukaryotic SV40 expression vector (Figure 8C). The
expression plasmids were transfected into HeLa cells together
with ,B-globin reporter plasmids containing either a normal
or a mutated octamer site in front of the 3-globin TATA
box (Figure 8D). Both target vectors carry a SV40 enhancer
downstream of the g-globin gene. This particular arrange-
ment of TATA box and octamer motif is transactivated by
Oct-2A (Muller-Immerfluck et al., 1988; 1990).
Expression of Oct-6, Oct4 and Oct-2A were confirmed
by the EMSA (Figure 8A). In the absence of a functional
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Fig. 8. Transcriptional activation via the octamer motif by cloned
Oct-6. (A) EMSA of ectopically expressed octamer binding proteins.
Whole cell extracts of HeLa cells with cotransfected Oct-2A, Oct-4 or
Oct-6 expression vectors were prepared and incubated before
electrophoresis with radiolabeled octamer probe. The vectors are
indicated above the figure and are outlined in (C). Lanes 1 to 3 are
from experiments with expression vectors with sense-orientated DNA,
lanes 4 and 5 with DNA orientated in anti-sense. In contrast to the
standard EMSA procedure half the amount of unspecific competitor
was used. A unspecific complex with a slightly higher mobility than
Oct-6 is marked with an arrow at the right side of the figure (for
discussion see text). (B) Transactivation via the octamer site as
determined by RNase protection. Lanes with uneven numbers:
cotransfection with an unmutated octamer motif (o+). Lanes with even
numbers: cotransfection with a mutated octamer motif (o-). The
position of the testgene (S) and of the reference gene (Ref) are
indicated at the left side of the figure. The expression vectors and
reporter vectors are indicated above the figure and outlined in (C) and
(D), respectively. (C) Expression vectors used for transactivation:
CMV-Oct2+, SV-Oct6+, SV-Oct-, CMV-Oct4+, CMV-Oct4-.
+ represents sense-orientation, - represents antisense-orientation of
the respective gene. Oct-2 and Oct-4 are driven by the CMV
enhancer/promoter, Oct-6 by the SV40 enhancer/promoter. (D) The
reporter plasmids contain either octamer motif sequences (o+) or a
mutated octamer motif (o-) in front of the ,B-globin gene. A SV40
enhancer is located in both vectors downstream of the (3-globin gene.
The reporter plasmids and their analysis are described by
Muller-Immergluck et al. (1988; 1990).
transactivator (Figure 8A, lanes 4 and 5), f-globin
expression was not detectable (Figure 8B, lanes 5, 6, 9 and
10). However, cotransfection of functional Oct-6 induced
gene expression significantly via the octamer motif (lanes
7 and 8). This stimulation is comparable to that of Oct-2A
and Oct-4 (lanes 1 and 3), clearly demonstrating that Oct-6
functions as a transactivator.
The 6W enhancer, containing six tandem repeats of a
mouse immunoglobulin heavy chain gene enhancer fragment,
is highly active in F9 stem cells where Oct-4 and Oct-6 are
present (Scholer et al., 1989b). Because transactivation
experiments in HeLa cells with cloned Oct-4 were not
successful (Scholer et al., 1990b), we wanted to determine
if Oct-6 is responsible for enhancer activation. For this
purpose, we used the same reporter vectors as for the Oct4
analysis (Scholer et al., 1990b), but again transactivation
of the 6W enhancer could not be achieved (not shown).
Therefore, none of the cloned octamer binding porteins show
enhancer activation but can only activate via an octamer motif
near the TATA box (Muller-Immergluck et al., 1988; 1990;
Scholer et al., 1990b; Tanaka and Herr, 1990; Okamoto
etal., 1990).
Discussion
We have reported cloning of a cDNA encoding the new
transcription factor Oct-6 activating transcription via the
octamer motif. As with the other embryonal stem cell
protein, Oct-4, Oct-6 is downregulated upon differentiation,
but is later expressed again in cells of the developing brain
and in testis. The temporal and spatial expression of Oct-6
was analyzed by Northern blot analysis, RNase protection,
in situ hybridization and DNA binding studies. A clear cor-
relation of Oct-6 RNA and Oct-6 protein is shown. The
proteolytic clipping assay confirmed the presence and identity
of Oct-6 as one of several octamer binding proteins in brain.
Oct-6 is encoded by the isolated cDNA
Several lines of evidence indicate that the cDNA described
in this study encodes Oct-6. First, four octamer binding
proteins (Oct-1, Oct-4, Oct-5 and Oct-6) were detected in
F9 stem cells. 18 clones from the F9 cDNA library fall into
three different groups, two encoding Oct-l, and Oct-4/Oct-5
(Scholer et al., 1990a). The third group comprises five
cDNA clones of a new gene coding for an octamer binding
POU protein. Second, the RNA detected with an Oct-6
specific probe is in agreement with the presence of DNA
binding activity. Third, brain Oct-6 is identified due to its
clipping pattern as the protein encoded by the cloned Oct-6.
Finally, the protein encoded by the cDNA has the same
mobility in the EMSA as F9 Oct-6 and brain Oct-6. The
brain and F9 Oct-6 cDNA clones are identical, except for
500 bp missing at the 5'end of the F9 cDNA. Thus we
cannot exclude the different exons are used for generating
the amino-terminus, although F9 and brain Oct-6 have the
same size in the EMSA, and the 3.6 and 2.8 kb Oct-6
mRNAS are found both in brain and in F9 cells.
Relationship of mouse Oct-6 and rat Tst-1ISCIP
The identity of the POU domain sequence indicate that Oct-6
and Tst-l (He et al., 1989) and SCIP cDNAs (Monuki et al.,
1989) are derived from homologous genes in mouse and rat.
A comparison of the restriction maps of Oct-6 and SCIP
supports this notion. The POU domain of both proteins is
located close to the carboxy terminus. Furthermore, each
restriction site in the SCIP coding region (Apal, PstI, SacIl)
is found at a similar position in that of Oct-6, although Oct-6
has additional sites not found in SCIP (SacI, Kpnl). The
different mRNA sizes and expression patterns might be due
to species specific differences, but might also indicate
expression from a different gene. This is not unlikely,
because several members of POU class III are almost
identical (He et al., 1989).
In the EMSA brain Oct-6 and NOct-3 almost have the
same mobility. However, the proteolytic clipping pattern of
both clearly demonstrate that both proteins are different
(Figure 5). Moreover, NOct-3 is present where Oct-6 RNA
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is not found (Figures 3 and 6). Therefore both proteins are
most likely derived from different genes and not due to
different modifications of the same protein. Candidates for
genes encoding NOct-3 are Bn- I and Bm-2 which are both
expressed in most regions of the rat brain (He et al., 1989).
NOct-3 is probably not encoded by Brn-3, because Brn-3
RNA is not found in rat cortex, whereas NOct-3 protein is.
Oct-6 expressed in embryonal stem cells, germ cells
and in brain
The embryonal stem cell line D3 and several other ES cell
lines (not shown) derived from the inner cell mass (ICM)
of blastocysts, contains Oct-6 protein, as does the embryonal
carcinoma cell line F9. Although Oct-6 RNA and protein
is definitely present in embryonal stem cells we could not
demonstrate Oct-6 expression in the blastocyst by in situ
hybridization. In contrast, Oct-4 expression was readily
detectable (Scholer et al., 1990b). This might be due to a
low level of Oct-6 expression as suggested by comparing
Oct-6 and Oct-4 expression in ES and EC cells, or to limited
transcription in only a few cells of the ICM. Moreover,
although we have detected Oct-6 in all of six different ES
and EC cell lines tested our experiments cannot rule out that
Oct-6 expression is induced by the very act of culturing EC
and ES cells. However, to our knowledge this has not been
shown for any gene expressed in ES cells. Oct-6 is also
expressed in primordial germ cells as determined by the
EMSA (not shown), furthermore in testis as shown by
Northern blot analysis (Figure 2).
Oct-6 expression during the migratory phase of cortical
neurogenesis is readily detectable in the cortical plate,
subependymal zone and in the olfactory bulb. The
widespread distribution of expression at embryonic day 12
and 14 and its expression in the cortical plate at day 17
indicate that Oct-6 is expressed in differentiating neurons.
This is similar to Tst-1ISCIP expression in rat brain (He et al.,
1989). However, at least two differences are found between
rat Tst-1ISCIP and mouse Oct-6 expression. In contrast to
decreasing Tst-IISCIP expression during brain development,
Oct-6 expression increases during the same period.
Furthermore, in contrast to Tst-1ISCIP expression in rat
cerebellum, no Oct-6 expression was detectable in this brain
region. Tst-1ISCIP is expressed by myelinating glial cells
(Schwann cells and oligodendrocytes), but not by
nonmyelinating glia (astrocytes). Because expression of
Tst-1ISCIP precedes induction of the major myelin genes,
it might play a role in cell-type specific expression of these
genes (Monuki et al., 1989).
Oct-6 protein is present in embryonal stem cells and in
the developing brain. Therefore this transcription factor could
be regulating different aspects of development. Since Oct-6
expression is turned down upon differentiation of ES cells
and is strongly increased at about day 11, the Oct-6 gene
might be expressed in a biphasic manner. In the first phase
it might act prior to other putative control genes, such as
Hox or Pax genes (reviewed in Dressler and Gruss, 1988;
Holland and Hogan, 1988; Kessel and Gruss, 1990). In the
latter case it might take part in setting up the temporal and
spatial patterns in mammalian brain development. Moreover,
because Oct-6 is also found in cells of the adult brain, it
might also be required for the maintenance of certain cellular
functions and thus act, similar to Oct-2, as a cell-specific
transcription factor.
The expression of Oct-6 is reminiscent of Drosophila
homeodomain genes such as fushi tarazu (ftz), which is
expressed early in development to play a critical role in
pattern formation, and later reappears in a limited number
of neurons (Doe et al., 1988). Another protein, the Cfla
gene product of Drosophila binds to a DNA element required
for expression of the dopa decarboxylase in selected
dopaminergic neurons (Johnson and Hirsch, 1990).
Interestingly, the POU domains of Oct-6 and Cfla are highly
conserved differing only in 12 of 140 amino acids. This
includes the linker of 17 amino acids between the POU
specific domain and POU homoeodomain which usually
differs greatly amoungst different POU domain proteins.
Besides these similarities, their amino acid sequences differ,
except for having histidine rich clusters surrounding the POU
domain.
Oct-6: activator, repressor or both?
Oct-6 and Oct-4 are two positively regulating transcription
factors present in ES and EC cells (Lenardo et al., 1989;
Scholer et al., 1989a,b; Scholer et al., 1990a,b; Okamoto
et al., 1990; Rosner et al., 1990). Repression and activation
via the octamer motif has been described in F9 cells (Lenardo
et al., 1989; Scholer et al., 1989b). Repression was shown
with an immunoglobulin heavy chain gene enhancer fragment
harboring the AcE3, ttE4 and octamer sites placed in front
of a truncated promoter of the fos gene (Lenardo et al.,
1989). The positive effect of AE3 on the promoter was block-
ed by binding of proteins to the octamer motif. It remains
to be tested, which octamer binding protein is responsible
for repression. However, it would not be surprising if one
or both of the cloned Oct-genes is responsible for both
activities, because activation and repression have been
described for several other eukaryotic transcription factors
(reviewed in Levine and Manley, 1989).
Oligomerization of the octamer motif creates a potent
enhancer in ES and EC cells (Sch6ler, 1989b). However,
transactivation of this enhancer in HeLa cells by cloned Oct-4
and Oct-6 could not be achieved. Therefore either an
inhibitory factor present in HeLa cells or a stimulatory factor
present in the ES and EC cells but missing in HeLa, might
account for this effect. Interestingly, both ES proteins contain
the same stretch of eight amino acids located between helix
one and two of the POU homoeodomain and thus might form
an identical hinge. Both helices surrounding this sequence
show about 40% homology to Oct-4, the highest homology
of the Oct-4/Oct-6 hinge to members of the other POU
classes (according to He et al., 1989) is 50%. We speculate
that this conserved amino acid reflects an interaction with
another protein. This would be similar to the interaction be-
tween the HSV protein VP16 with Oct-I (Gerster et al.,
1988; Triezenberg et al., 1988; Kristie et al., 1989) at the
next hinge between helix two and three (Stern et al., 1989).
Expression of VP16 in cells merely containing Oct-I
activates the octamer motif in otherwise inactive promoters
(O'Hare and Goding, 1988; O'Hare et al., 1988; Tanaka
et al., 1988). Whether a similar interaction between the
conserved Oct-4/Oct-6 hinge with a (stem cell specific) factor
exists, and particularly, if enhancer activation in stem cell
is due to such an interaction, will be tested.
Oct-6 is present in ES cells, in the developing and in the
adult brain. Therefore this transcription factor could be
regulating very early developmental proceses, acting prior
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to other putative control genes, such as Pax or Hox genes.
It will be interesting to determine if Oct-6 regulates members
of these families (Kessel and Gruss, 1990). Furthermore,
Oct-6 may regulate late processes, such as brain
development. Taken together, we think that Oct-6 is a good
candidate for a gene involved in control events of murine
development.
Materials and methods
Standard techniques of molecular biology were performed as in Sambrook
et al., (1989), standard techniques for mouse embryology were performed
as in Hogan et al., (1986).
Cell lines and transfections for transactivation
HeLa, F9 and D3 cells were grown and transfected as described elsewhere
(Scholer and Gruss, 1984; Scholer et al., 1989a, b). HeLa cells were
transfected by 8 Ag reporter plasmid, 4 Ag expression vectors and 1 jg
reference plasmid and 7 Ag Bluescript as carrier DNA. After harvesting
of the cells two days later, 1/10 of the cells were used for the microextraction
procedure. The RNA of the rest was extracted and analyzed by RNase
protection. The transactivation analysis was done twice.
Preparation of the F9 and brain cDNA library
A directional cloned F9 cDNA library in the X expression vector XZAPII
(Stratagene) was constructed as described (Scholer et al., 1990a), a mouse
brain cDNA library in the X expression vector XZAPII was constructed with
the cDNA synthesis kit (Pharmacia) in accordance with the manufacturer's
specification. Sequencing was performed as described previously (Scholer
et al., 1990a).
Recombinant plasmids and oligonucleotides
SV-Oct6+ and SV-Oct6- were obtained by cloning the complete Oct-6
coding sequence in a SV40 expression vector based on pBR322. Expres-
sion is driven by the SV40 enhancer/promoter region (Pvull to HindIII),
one 72 bp deleted in the SV40 enhancer (Tooze, 1981). A 610 bp Sau3A
fragment ofSV40 with the small t-intron and a 257 bp SV40 fragment (BcII
to BamHI) with transcriptional termination sequences follow the promoter
fragment. The Hindi between promoter and t-intron was converted to Bgll.
For cloning of Oct-6 the plasmid containing the Oct-6 cDNA was cut with
Hindu and BamHI in the polylinker upstream and downstream of the cDNA,
respectively. The ends were blunt-ended and cloned in both orientations
into the blunt-ended Bgll site of the expression vector. The orientation of
the insert was determined by restiction with X7hoI and BanHI. CMV-ct4+
and CMV-Oct4- clone were described by Scholer et al. (1990b),
CMV-Oct2A(+) by Muller-Immergluck et al. (1988). The octamer
containing probe was also described previously (1W in Scholer et al., 1989a).
In vitro translation in reticulocyte lysates
In vitro transcription and translation of Oct-4 and Oct-6 was performed as
described previously (Scholer et al., 1990a). Before in vitro transcription
the Oct-6 cDNA clone was restricted with BamHI to obtain sense RNA
with T7 RNA polymerase or with HinduI to obtain anti-sense RNA with
T3 RNA polymerase.
Microextraction procedure for the preparation of whole
extracts, electrophoretic mobility shift assay (EMSA)
proteolytic clipping
These methods were performed as described previously (Scholer et al.,
1989a; 1990b).
Northern blot analysis and RNase protection assay
Northern blot analysis was performed as described previously (Scholer et al.,
1990a). RNase protection assays were performed essentially as described
by Balling et al., (1989).
In situ hybridization
The techniques employed for in situ hybridization are in Scholer et al.,
(1990b). A 160 bp Oct-6 cDNA fragment (fragment A in Figure IA) was
cloned into Bluescript (Stratagene) and linearized with an appropriate
restriction endonuclease. RNA probes were transcribed using T3 and T7
polymerases according to the manufacturer's instructions (Promega).
Acknowledgements
We thank C.Peiker for her excellent technical assistance and R.Altschaffel
for the photographic work. We further thank A.Mansouri for the supply
of D3 cells, B.Fohring for help with the computer and are grateful to
M.Gross, A.Puschel and M.Golding for valuable comments on the
manuscript. We further thank W.Schaffner and his colleagues for CMV-
Oct2 + and the reporter plasmids. N.S. is a recipient of the Behrens-Weise
Foundation. H.R. was supported by a Boehringer Ingelheim Fond
Fellowship. T.N. was supported by a Max-Planck Fellowship. This project
was supported by the Max-Planck Society and by the Bundesministerium
fur Forschung und Technologie (BMFT).
References
Akam,M. (1987) Development, 101, 1-22.
Balling,R., Mutter,G., Gruss,P. and Kessel,M. (1989) Cell, 58, 337-347.
Davidson,E.H. (1990) Development, 108, 365-389.
Doe,C.Q., Hiromi,Y., Gehring,W.J. and Goodman,C.S. (1988) Science
239, 170-175.
Doetschman,T., Eistetter,H., Katz,M., Schmidt,W. and Kemler,R. (1985)
J. Embryol. Erp. Morphol., 87, 27-45.
Dressler,G.R. and Gruss,P. (1988) Trends Genet., 4, 214-219.
Evans,M.J. and Kaufman,M.H. (1981) Nature, 292, 154-156.
Falkner,F.G., Mocinat,R. and Zachau,H.G. (1986) Nucleic Acids Res.,
14, 8819-8827.
Frasch,M., Hoey,T., Rushlow,C. and Levine,M. (1987) EMBO J., 6,
749-759.
Garcia-Blanco,M.A., Clerc,R.G. and Sharp,P.A. (1989) Genes Dev., 3,
739-745.
Gardner,R.L. and Rossant,J. (1979) J. Embryol. Exp. Morphol., 52,
141- 152.
Gerster,T. and Roeder,R.G. (1988) Proc. Natl. Acad. Sci. USA, 85,
6347 -6351.
Hatzopoulos,A.K., Schlokat,U. and Gruss,P. (1988). In Hames,B.D. and
Glover,D.M. (eds), Transcription and Splicing. Frontiers in Molecular
Biology. IRL Press, Oxford, pp. 43-96
Hatzopoulos,A.K., Stoykova,A.S., Erselius,J.R., Golding,M., Neuman,T.
and Gruss,P. (1990) Development, 109, 349-362.
He,X., Tracy,M.N., Simmons,D.M., Ingraham,H.A., Swanson,L.W. and
Rosenfeld,M.G. (1989) Nature, 340, 35-42.
Herr,W., Sturm,R.A., Clerc,R.G. Corcoran,L.M., Baltimore,D.,
Sharp,P.A., Ingraham,H.A., Rosenfeld,M.G., Finney,M., Ruvkun,G.
and Horvitz,H.R. (1988) Genes Dev., 2, 1513-1516.
Hogan,B., Constantini,F. and Lacy,E. (1986). Manipulating the Mouse
Embryo: a Laboratory Manual. Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY, USA.
Holland,P.W.H. and Hogan,B.L.M. (1988) Genes Dev., 2, 773-782.
Ingham,P. (1988) Nature, 335, 25-34.
Iwanaga,S., Kato,H., Sugo,T., Ikari,N., Hashimoto,N. and Fujii,S. (1979).
In Holzer,H. and Tschesche,H. (eds), Biological Functions of Proteinases.
Springer Verlag, Berlin, pp. 243 -359.
Johnson,W.A., and Hirsch,J. (1990) Nature, 343, 467-470.
Kato,H., Nagasawa,S. and Suzuki,T. (1983) Nature, 305, 545-549.
Kessel,M., and Gruss,P. (1990) Science, 249, 374-379.
Kristie,T.M., LeBowitz,J.H. and Sharp,P. (1989) EMBO J., 8,4229-4238.
Lenardo,M.J., Staudt,L., Robbins,P., Kuang,A., Mulligan,R.C. and
Baltimore,D. (1989) Science, 243, 544-546.
Levine,M., and Manley,J.L. (1989) Cell, 59, 405-408.
Lottspeich,F., Kellermann,J., Henschen,A., Foertsch,B. and
Muller-Esterl,W. (1985) Eur. J. Biochem. 152, 307-314.
McDonald,P.M., Ingham,P. and Struhl,G. (1986) Cell, 47, 721-734.
McKnight,J.L.C., Pellett,P.E., Jenkins,F.J. and Roizman,B. (1987) J.
Virol., 61, 992-1001.
Martin,G.R. (1981) Proc. Natl. Acad Sci. USA, 78, 7634-7638.
Mitchell,P.J. and Tjian,R. (1989) Science, 245, 371-378,
Monuki,E.S., Weinmaster,G., Kuhn,R. and Lemke,G. (1989) Neuron, 2,
783-793.
Muiller-Immergluck,M.M., Ruppert,S., Schaffner,W. and Matthias,P.
(1988) Nature, 336, 544-551.
Muiller-Immerglick,M.M., Schaffner,W. and Matthias,P. (1990) EMBO J.,
9, 1625-1634.
O'Hare,P. and Goding,C.R. (1988) Cell, 52, 435-445.
O'Hare,P., Goding,C.R. and Haigh,A. (1988) EMBO J., 7, 4231-4238.
Okamoto,K., Okazawa,H., Okuda,A., Sakai,M., Muramatsu,M. and
Hamada,H. (1990) Cell, 60, 461-472.
3731
N.Suzuki et al.
Otting,G., Quian,Y.Q., Muller,M., Alfolter,M., Gehring,W.J. and
Wuthrich,K. (1988) EMBO J., 7, 4305-4309.
Poole,S.J., Kauver,L.M., Drees,B. and Kornberg,T. (1985) Cell, 40,
37-43.
Quian,Y.Q., Billeter,M., Otting,G., Muller,M., Gehring,W.J. and
Wuthrich,K. (1989) Cell, 59, 573-580.
Rickmann,M. and Wolff,J.R. (1985) Adv. Anat. Embryol. Cell. Biol., 93,
1-100.
Rosner,M.H., Vigano,M.A., Ozato,K., Timmons,P.M., Poirier,F.,
Rigby,P.W.J. and Staudt,L.M. (1990) Nature, 345, 686-692.
Sambrook,J., Fritsch,E.F. and Maniatis,T. (1989) Molecular Cloning: a
Laboratory Manual. (2nd edition) Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY, USA.
Schaffner,W. (1989) Trends Genet., 5, 37-39
Scholer,H.R. and Gruss,P. (1984) Cell, 36, 403-411.
Scholer,H.R., Hatzopoulos,A.K., Balling,R., Suzuki,N. and Gruss,P.
(1989a) EMBO J., 8, 2543-2550.
Scholer,H.R., Balling,R. Hatzopoulos,A.K., Suzuki,N. and Gruss,P.
(1989b) EMBO J., 8, 2551-2557.
Scholer,H.R., Ruppert,S., Suzuki,N., Chowdhury,K. and Gruss,P. (1990a)
Nature, 344, 435-439.
Scholer,H.R., Dressler,G.R., Balling,R., Rohdewohld,H. and Gruss,P.
(1990b) EMBO J., 9, 2185-2195.
Schreiber,E., Matthias,P., Muller-Immergluck,M.M. and Schaffner,W.
(1988) EMBO J., 7, 4221-4229.
Schreiber,E., Muller-Immergluck,M.M. Schaffner,W. and Matthias,P.
(1989) In Renkawitz,R. (ed), Tissue Specific Gene Expression. Verlag
Chemie, Weinheim, pp. 33-54.
Stern,S., Tanaka,M. and Herr,W. (1989) Nature, 341, 624-630.
Tanaka,M., Grossniklaus,U., Herr,W. and Hernandez,N. (1988) Genes
Dev., 2, 1764-1778.
Tanaka,M. and Herr,W. (1990) Cell, 60, 375-386.
Tooze,J. (ed.) (1981). DNA Tumor Viruses, 2nd ed. (Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY, USA.
Triezenberg,S.J., LaMarco,K.L. and McKnight,S.L. (1988) Genes Dev.,
2, 730-742.
Received on July 10, 1990; revised on August 15, 1990
3732
